Egan Christopher
Director at CCCS; Director at TRU
- Sold, on record
- $3B
- Dollars the filings state
- Form 4 sales
- 16
- Latest Mar 3, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale CCCSPlan not statedApr 11 2022
Sold 17.5M shares at $9.28 ($162M)
Egan Christopher, Director
Sold 16.8% of holdings ($964M position)86.4M shares leftFirst sale on recordFiling
- 2 Form 4 sale CCCSUnusualNov 13 +581 days
Sold 69.9M shares at $10.11 ($706M)
Egan Christopher, Director
No 10b5-1 planSold 100% of holdings ($706M position)0 shares leftFiling
- 3 Form 4 sale CCCSUnusualJan 8 +56 days
Sold 22M shares at $10.47 ($230M)
Egan Christopher, Director
No 10b5-1 planSold 25.5% of holdings ($902M position)64.2M shares leftFiling
- 4 Form 4 sale CCCSUnusualMar 4 +56 days
Sold 41.2M shares at $11.33 ($466M)
Egan Christopher, Director
No 10b5-1 planSold 43.2% of holdings ($1.1B position)54.1M shares left1.9x usual sizeFiling
- 5 Form 4 sale CCCSNo planApr 9 +36 days
Sold 16.6M shares at $11.58 ($193M)
Egan Christopher, Director
No 10b5-1 planSold 24.9% of holdings ($773M position)50.1M shares left0.5x usual sizeFiling
- 6 Form 4 sale CCCSUnusualMay 30 +51 days
Sold 41.6M shares at $11.43 ($476M)
Egan Christopher, Director
No 10b5-1 planSold 51% of holdings ($933M position)40M shares left1.3x usual sizeFiling
- 7 Form 4 sale CCCSUnusualJul 1 +32 days
Sold 25M shares at $11.30 ($282M)
Egan Christopher, Director
No 10b5-1 planSold 42.4% of holdings ($665M position)33.9M shares left0.6x usual sizeFiling
- 8 Form 4 sale CCCSUnusualMar 3 +245 days
Sold 42M shares at $10.33 ($434M)
Egan Christopher, Director
No 10b5-1 planSold 63.9% of holdings ($678M position)23.7M shares left1.3x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (16)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Mar 3, 2025 | CCCS | Director | Form 4 sale | 42M | $434M | 63.9% | Unusual | SEC |
| Jul 1, 2024 | CCCS | Director | Form 4 sale | 25M | $282M | 42.4% | Unusual | SEC |
| May 30, 2024 | CCCS | Director | Form 4 sale | 41.6M | $476M | 51.0% | Unusual | SEC |
| Apr 9, 2024 | CCCS | Director | Form 4 sale | 16.6M | $193M | 24.9% | No plan | SEC |
| Mar 4, 2024 | CCCS | Director | Form 4 sale | 41.2M | $466M | 43.2% | Unusual | SEC |
| Jan 8, 2024 | CCCS | Director | Form 4 sale | 22M | $230M | 25.5% | Unusual | SEC |
| Nov 13, 2023 | CCCS | Director | Form 4 sale | 69.9M | $706M | 100.0% | Unusual | SEC |
| Apr 11, 2022 | CCCS | Director | Form 4 sale | 17.5M | $162M | 16.8% | Plan not stated | SEC |
| Nov 2, 2017 | TRU | Director | Form 4 sale | 62,129 | $3.2M | 100.0% | Unusual | SEC |
| Aug 4, 2017 | TRU | Director | Form 4 sale | 201,753 | $9.2M | 76.5% | Unusual | SEC |
| May 2, 2017 | TRU | Director | Form 4 sale | 185,262 | $7.3M | 41.2% | Unusual | SEC |
| Mar 22, 2017 | TRU | Director | Form 4 sale | 16,674 | $610k | 3.6% | Plan not stated | SEC |
| Feb 22, 2017 | TRU | Director | Form 4 sale | 163,472 | $6M | 26.0% | Unusual | SEC |
| Sep 14, 2016 | TRU | Director | Form 4 sale | 132,821 | $4.4M | 17.4% | Plan not stated | SEC |
| Jun 10, 2016 | TRU | Director | Form 4 sale | 302,401 | $9.5M | 28.4% | Unusual | SEC |
| Mar 14, 2016 | TRU | Director | Form 4 sale | 150,175 | $3.6M | 12.4% | Plan not stated | SEC |